Neoadjuvant M-VAC (Methotrexate, Vinblastine, Adriamycin, and Cisplatin) Chemotherapy and Bladder Preservation for Muscle-Infiltrating Transitional Cell Carcinoma of the Bladder

By Sternberg C.N.   Pansadoro V.   Lauretti S.   Platania A.   Giannarelli D.   Rossetti A.   De Carli P.   Arena M.G.   Cancrini A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite

Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder

By Raghavan D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 468-474

Elsevier

Access to resources Recommend Favorite

Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire

By Karagas Margaret R.   Tosteson Tor D.  

Cancer Causes and Control, Vol. 15, Iss. 5, 2004-06 ,pp. : 465-472

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy for non-small cell lung cancer: the new standard of care

By Laskin Janessa J  

Future Oncology, Vol. 1, Iss. 5, 2005-10 ,pp. : 619-623

Future Medicine

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for bladder cancer

By Millikan R.   Siefker-Radtke A.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 464-467

Elsevier

Access to resources Recommend Favorite